Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. (Q36293343)

From Wikidata
Jump to: navigation, search
scientific article
edit
Language Label Description Also known as
English
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
scientific article

    Statements

    Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. (English)
    0 references
    0 references
    0 references
    Dalil Hannani
    Marie Vétizou
    David Enot
    David Klatzmann
    Melanie Desbois
    Nicolas Jacquelot
    Nadège Vimond
    Salem Chouaib
    Christine Mateus
    James P Allison
    Antoni Ribas
    Jedd D Wolchok
    Jianda Yuan
    Philip Wong
    Michael Postow
    Andrzej Mackiewicz
    Jacek Mackiewicz
    Dirk Schadendorff
    Dirk Jaeger
    Inka Zörnig
    Jessica Hassel
    Alan J Korman
    Keith Bahjat
    Michele Maio
    Luana Calabro
    Michele Wl Teng
    Mark J Smyth
    Alexander Eggermont
    Caroline Robert
    Guido Kroemer
    13 January 2015
    208-224

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit